Feed icon


Prof John Hardy

Prof John Hardy is the first UK winner of $3m Breakthrough Prize in Life Sciences

Professor John Hardy (UCL Institute of Neurology) has been awarded the $3 million Breakthrough Prize in Life Sciences for his pioneering research into the genetic causes of Alzheimer’s disease, other forms of dementia and Parkinson’s disease. More...

John Hardy, PhD, right, accepted the 2015 Robert A. Pritzker Prize from MJFF VP Brian Fiske, PhD, and Michael J. Fox on April 15.

John Hardy awarded 2015 Robert A. Pritzker Prize for Leadership in Parkinson's Research

One of the UK Parkinson's Disease Consortium Principal Investigators, Prof John Hardy, has been awarded the 2015 Robert A. Pritzker Prize for his leadership in Parkinson's genetics research. The award was presented by Michael J. Fox at a ceremony in New York on April 15. From the Michael J. Fox Foundation website: More...

Webcast - Prof Nicholas Wood - Advances in Genetic Understanding of Parkinson's Disease.

Video: Advances in Genetic Understanding of Parkinson's Disease

Webcast of the presentation entitled ‘Advances in Genetic Understanding of Parkinson's Disease’ given by Nicholas Wood (University College London, United Kingdom) presented at the Biochemical Society Hot Topic event, PINK1-Parkin Signalling in Parkinson’s Disease and Beyond, held in December 2014. More...

Pedigrees and I-FP-CIT SPECT scan images of the four families with GCH1 mutations involved in this study.

GCH1 gene and Parkinson's risk

A study published in Brain, led by researchers at UCL Institute of Neurology, has shown that genetic mutations which cause a decrease in dopamine production in the brain and lead to a form of childhood-onset Dystonia, also play a role in the development of Parkinson’s disease.

Leonard Wolfson Experimental Neurology Centre (LWENC)

The new Leonard Wolfson Experimental Neurology Centre (LWENC) has opened for clinical studies and trials


Laura Osellame

(Former Research Associate)

Laura Osellame

Mitochondrial Morphology and distribution. Apoptosis, autophagy and mitochondrial electron transport chain function in relation to Parkinson’s Disease.


Contact details

Lab website

Link to Publications RSS button
Jump to: 2013 | 2012 | 2011 | 2008
Number of items: 6.


Osellame, LD; Rahim, AA; Hargreaves, IP; Gegg, ME; Richard-Londt, A; Brandner, S; Waddington, SN; (2013) Mitochondria and quality control defects in a mouse model of Gaucher Disease-links to Parkinson's Disease. Cell Metabolism , 17 (6) pp. 941-953. 10.1016/j.cmet.2013.04.014. Green open access


Osellame, LD; Blacker, TS; Duchen, MR; (2012) Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab , 26 (6) pp. 711-723. 10.1016/j.beem.2012.05.003. Gold open access

Osellame, LD; Rahim, A; Gegg, ME; Waddington, S; Schapira, AHV; Duchen, MR; (2012) Accumulation of damaged mitochondria in neuropathic Gaucher disease, the most prevalent risk factor for Parkinson's disease, is due to defective cellular degradation machinery. Presented at: UNSPECIFIED.


Palmer, CS; Osellame, LD; Laine, D; Koutsopoulos, OS; Frazier, AE; Ryan, MT; (2011) MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO REP , 12 (6) 565 - 573. 10.1038/embor.2011.54.

Palmer, CS; Osellame, LD; Stojanovski, D; Ryan, MT; (2011) The regulation of mitochondrial morphology: Intricate mechanisms and dynamic machinery. CELL SIGNAL , 23 (10) 1534 - 1545. 10.1016/j.cellsig.2011.05.021.


Osellame, LD; Koutsopoulos, OS; Laine, D; Frazier, AE; Ryan, MT; (2008) MiD51 and MiD49: New mediators of mammalian mitochondrial distribution. In: BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS. (pp. S57 - S57). ELSEVIER SCIENCE BV

This list was generated on Sun Nov 22 09:54:21 2015 GMT.

Page last modified on 12 feb 14 14:42